Drug Shortage Report for ANORO ELLIPTA
Report ID | 73358 |
Drug Identification Number | 02418401 |
Brand name | ANORO ELLIPTA |
Common or Proper name | umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | Vilanterol Umeclidinium |
Strength(s) | 25MCG 62.5MCG |
Dosage form(s) | POWDER |
Route of administration | INHALATION |
Packaging size | 1x7 |
ATC code | R03AL |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-01-18 |
Estimated end date | 2019-02-15 |
Actual end date | 2019-02-07 |
Shortage status | Resolved |
Updated date | 2019-02-08 |
Company comments | 30 dose format is available. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2019-02-08 | English | Compare |
v2 | 2019-01-23 | French | Compare |
v1 | 2019-01-23 | English | Compare |
Showing 1 to 3 of 3